Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

TOX3 gene variant could be associated with painful restless legs.

Karroum EG, Saini PS, Trotti LM, Rye DB.

Sleep Med. 2019 Jul 11;65:4-7. doi: 10.1016/j.sleep.2019.07.003. [Epub ahead of print]

PMID:
31706190
2.

Focus on the pedunculopontine nucleus. Consensus review from the May 2018 brainstem society meeting in Washington, DC, USA.

Garcia-Rill E, Saper CB, Rye DB, Kofler M, Nonnekes J, Lozano A, Valls-Solé J, Hallett M.

Clin Neurophysiol. 2019 Jun;130(6):925-940. doi: 10.1016/j.clinph.2019.03.008. Epub 2019 Mar 28. Review.

PMID:
30981899
3.

Inter-rater agreement for visual discrimination of phasic and tonic electromyographic activity in sleep.

Bliwise DL, Fairley J, Hoff S, Rosenberg RS, Rye DB, Schulman DA, Trotti LM.

Sleep. 2018 Jul 1;41(7). doi: 10.1093/sleep/zsy080.

PMID:
29722892
4.

Systemic exertion intolerance disease/chronic fatigue syndrome is common in sleep centre patients with hypersomnolence: A retrospective pilot study.

Maness C, Saini P, Bliwise DL, Olvera V, Rye DB, Trotti LM.

J Sleep Res. 2019 Jun;28(3):e12689. doi: 10.1111/jsr.12689. Epub 2018 Apr 6.

PMID:
29624767
5.

Postnatal hypoxia evokes persistent changes within the male rat's dopaminergic system.

Decker MJ, Jones KA, Keating GL, Rye DB.

Sleep Breath. 2018 May;22(2):547-554. doi: 10.1007/s11325-017-1558-6. Epub 2017 Aug 22.

PMID:
28828549
6.

Hypocretin measurement: shelf age of radioimmunoassay kit, but not freezer time, influences assay variability.

Keating G, Bliwise DL, Saini P, Rye DB, Trotti LM.

Scand J Clin Lab Invest. 2017 Sep;77(5):390-393. doi: 10.1080/00365513.2017.1325928. Epub 2017 May 24.

7.

Rigor, reproducibility, and in vitro cerebrospinal fluid assays: The devil in the details.

Moody OA, Talwar S, Jenkins MA, Freeman AA, Trotti LM, García PS, Bliwise D, Lynch JW, Cherson B, Hernandez EM, Feldman N, Saini P, Rye DB, Jenkins A.

Ann Neurol. 2017 Jun;81(6):904-907. doi: 10.1002/ana.24940. Epub 2017 Jun 1. No abstract available.

8.

Hypersomnia: Evaluation, Treatment, and Social and Economic Aspects.

Saini P, Rye DB.

Sleep Med Clin. 2017 Mar;12(1):47-60. doi: 10.1016/j.jsmc.2016.10.013. Review.

PMID:
28159097
9.

In Reply.

Safavynia SA, Keating G, Speigel I, Fidler JA, Kreuzer M, Rye DB, Jenkins A, García PS.

Anesthesiology. 2017 Feb;126(2):352-353. doi: 10.1097/ALN.0000000000001446. No abstract available.

10.

Genetics of restless legs syndrome.

Winkelmann J, Schormair B, Xiong L, Dion PA, Rye DB, Rouleau GA.

Sleep Med. 2017 Mar;31:18-22. doi: 10.1016/j.sleep.2016.10.012. Epub 2016 Nov 12.

PMID:
28065402
11.

Animal models of RLS phenotypes.

Allen RP, Donelson NC, Jones BC, Li Y, Manconi M, Rye DB, Sanyal S, Winkelmann J.

Sleep Med. 2017 Mar;31:23-28. doi: 10.1016/j.sleep.2016.08.002. Epub 2016 Sep 2. Review.

12.

Flumazenil for the Treatment of Refractory Hypersomnolence: Clinical Experience with 153 Patients.

Trotti LM, Saini P, Koola C, LaBarbera V, Bliwise DL, Rye DB.

J Clin Sleep Med. 2016 Oct 15;12(10):1389-1394.

13.

Effects of γ-Aminobutyric Acid Type A Receptor Modulation by Flumazenil on Emergence from General Anesthesia.

Safavynia SA, Keating G, Speigel I, Fidler JA, Kreuzer M, Rye DB, Jenkins A, García PS.

Anesthesiology. 2016 Jul;125(1):147-58. doi: 10.1097/ALN.0000000000001134.

14.

The Molecular Genetics of Restless Legs Syndrome.

Rye DB.

Sleep Med Clin. 2015 Sep;10(3):227-33, xii. doi: 10.1016/j.jsmc.2015.05.015. Epub 2015 Jul 2. Review.

PMID:
26329432
15.

Clarithromycin in γ-aminobutyric acid-Related hypersomnolence: A randomized, crossover trial.

Trotti LM, Saini P, Bliwise DL, Freeman AA, Jenkins A, Rye DB.

Ann Neurol. 2015 Sep;78(3):454-65. doi: 10.1002/ana.24459. Epub 2015 Jun 30.

16.

Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.

Weinberger JF, Raison CL, Rye DB, Montague AR, Woolwine BJ, Felger JC, Haroon E, Miller AH.

Brain Behav Immun. 2015 Jul;47:193-200. doi: 10.1016/j.bbi.2014.12.016. Epub 2014 Dec 18.

17.

Further experience using clarithromycin in patients with Kleine-Levin syndrome.

Trotti LM, Bliwise DL, Rye DB.

J Clin Sleep Med. 2014 Apr 15;10(4):457-8. doi: 10.5664/jcsm.3634. No abstract available.

18.

Wavelet analysis for detection of phasic electromyographic activity in sleep: influence of mother wavelet and dimensionality reduction.

Fairley JA, Georgoulas G, Smart OL, Dimakopoulos G, Karvelis P, Stylios CD, Rye DB, Bliwise DL.

Comput Biol Med. 2014 May;48:77-84. doi: 10.1016/j.compbiomed.2013.12.011. Epub 2014 Jan 11.

19.

Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience.

Trotti LM, Saini P, Freeman AA, Bliwise DL, García PS, Jenkins A, Rye DB.

J Psychopharmacol. 2014 Jul;28(7):697-702. doi: 10.1177/0269881113515062. Epub 2013 Dec 3.

PMID:
24306133
20.

Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia.

Trotti LM, Staab BA, Rye DB.

J Clin Sleep Med. 2013 Aug 15;9(8):789-95. doi: 10.5664/jcsm.2922.

21.

The molecular basis of restless legs syndrome.

Freeman AA, Rye DB.

Curr Opin Neurobiol. 2013 Oct;23(5):895-900. doi: 10.1016/j.conb.2013.07.001. Epub 2013 Jul 26. Review.

PMID:
23896312
22.

Restless legs syndrome, pica, and iron status in blood donors.

Spencer BR, Kleinman S, Wright DJ, Glynn SA, Rye DB, Kiss JE, Mast AE, Cable RG; REDS-II RISE Analysis Group.

Transfusion. 2013 Aug;53(8):1645-52. doi: 10.1111/trf.12260. Epub 2013 Jun 13.

23.

A prospective photographic study of the ocular fundus in obstructive sleep apnea.

Fraser CL, Bliwise DL, Newman NJ, Lamirel C, Collop NA, Rye DB, Trotti LM, Biousse V, Bruce BB.

J Neuroophthalmol. 2013 Sep;33(3):241-6. doi: 10.1097/WNO.0b013e318290194f.

24.

Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates.

Felger JC, Mun J, Kimmel HL, Nye JA, Drake DF, Hernandez CR, Freeman AA, Rye DB, Goodman MM, Howell LL, Miller AH.

Neuropsychopharmacology. 2013 Oct;38(11):2179-87. doi: 10.1038/npp.2013.115. Epub 2013 May 9.

25.

Obstructive sleep apnea in idiopathic intracranial hypertension: comparison with matched population data.

Thurtell MJ, Trotti LM, Bixler EO, Rye DB, Bliwise DL, Newman NJ, Biousse V, Bruce BB.

J Neurol. 2013 Jul;260(7):1748-51. doi: 10.1007/s00415-013-6858-6. Epub 2013 Feb 15.

26.

Restless legs syndrome in children with chronic kidney disease.

Riar SK, Leu RM, Turner-Green TC, Rye DB, Kendrick-Allwood SR, McCracken C, Bliwise DL, Greenbaum LA.

Pediatr Nephrol. 2013 May;28(5):773-95. doi: 10.1007/s00467-013-2408-9. Epub 2013 Jan 20.

PMID:
23334386
27.

Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors.

Rye DB, Bliwise DL, Parker K, Trotti LM, Saini P, Fairley J, Freeman A, Garcia PS, Owens MJ, Ritchie JC, Jenkins A.

Sci Transl Med. 2012 Nov 21;4(161):161ra151. doi: 10.1126/scitranslmed.3004685.

28.

Restless legs syndrome and periodic leg movements of sleep.

Rye DB, Trotti LM.

Neurol Clin. 2012 Nov;30(4):1137-66. doi: 10.1016/j.ncl.2012.08.004. Review.

PMID:
23099132
30.

Daytime REM sleep in Parkinson's disease.

Bliwise DL, Trotti LM, Juncos JJ, Factor SA, Freeman A, Rye DB.

Parkinsonism Relat Disord. 2013 Jan;19(1):101-3. doi: 10.1016/j.parkreldis.2012.08.003. Epub 2012 Aug 29.

31.

Daytime alertness in Parkinson's disease: potentially dose-dependent, divergent effects by drug class.

Bliwise DL, Trotti LM, Wilson AG, Greer SA, Wood-Siverio C, Juncos JJ, Factor SA, Freeman A, Rye DB.

Mov Disord. 2012 Aug;27(9):1118-24. doi: 10.1002/mds.25082. Epub 2012 Jul 2.

32.

Elevated C-reactive protein is associated with severe periodic leg movements of sleep in patients with restless legs syndrome.

Trotti LM, Rye DB, De Staercke C, Hooper WC, Quyyumi A, Bliwise DL.

Brain Behav Immun. 2012 Nov;26(8):1239-43. doi: 10.1016/j.bbi.2012.06.003. Epub 2012 Jun 26.

33.

Sleep fragmentation and motor restlessness in a Drosophila model of Restless Legs Syndrome.

Freeman A, Pranski E, Miller RD, Radmard S, Bernhard D, Jinnah HA, Betarbet R, Rye DB, Sanyal S.

Curr Biol. 2012 Jun 19;22(12):1142-8. doi: 10.1016/j.cub.2012.04.027. Epub 2012 May 31.

34.

Respect for muscle.

Bliwise DL, Rye DB.

Sleep. 2012 Jun 1;35(6):743-4. doi: 10.5665/sleep.1856. No abstract available.

35.

Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease.

Bliwise DL, Trotti LM, Yesavage JA, Rye DB.

Eur J Neurol. 2012 Jun;19(6):918-23. doi: 10.1111/j.1468-1331.2012.03673.x. Epub 2012 Feb 16.

36.

Restless abdomen: a phenotypic variant of restless legs syndrome.

Pérez-Díaz H, Iranzo A, Rye DB, Santamaría J.

Neurology. 2011 Sep 27;77(13):1283-6. doi: 10.1212/WNL.0b013e318230207a. Epub 2011 Sep 14.

PMID:
21917771
37.

The Berlin questionnaire screens for obstructive sleep apnea in idiopathic intracranial hypertension.

Thurtell MJ, Bruce BB, Rye DB, Newman NJ, Biousse V.

J Neuroophthalmol. 2011 Dec;31(4):316-9. doi: 10.1097/WNO.0b013e31821a4d54.

38.

Restless legs syndrome.

Trotti LM, Rye DB.

Handb Clin Neurol. 2011;100:661-73. doi: 10.1016/B978-0-444-52014-2.00047-1. Review.

PMID:
21496614
39.

Heart rate changes accompanying periodic leg movements during sleep in narcoleptic patients.

Ferri R, Zucconi M, Rye DB.

Sleep. 2011 Apr 1;34(4):409-10; author reply 411-2. No abstract available.

40.

Phasic Electromyographic Metric detection based on wavelet analysis.

Fairley JA, Georgoulas G, Stylios CD, Vachtsevanos G, Rye DB, Bliwise DL.

Mediterr Conf Control Automation. 2011. doi: 10.1109/MED.2011.5983202.

41.

Paradoxical sleep suppresses immediate early gene expression in the rodent suprachiasmatic nuclei.

Decker MJ, Rye DB, Lee SY, Strohl KP.

Front Neurol. 2010 Sep 22;1:122. doi: 10.3389/fneur.2010.00122. eCollection 2010.

42.

Phasic muscle activity in sleep and clinical features of Parkinson disease.

Bliwise DL, Trotti LM, Greer SA, Juncos JJ, Rye DB.

Ann Neurol. 2010 Sep;68(3):353-9. doi: 10.1002/ana.22076.

43.

Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol.

Raison CL, Rye DB, Woolwine BJ, Vogt GJ, Bautista BM, Spivey JR, Miller AH.

Biol Psychiatry. 2010 Nov 15;68(10):942-9. doi: 10.1016/j.biopsych.2010.04.019. Epub 2010 May 26.

45.

Wake promoting effects of cocaine and amphetamine-regulated transcript (CART).

Keating GL, Kuhar MJ, Bliwise DL, Rye DB.

Neuropeptides. 2010 Jun;44(3):241-6. doi: 10.1016/j.npep.2009.12.013. Epub 2010 Feb 8.

47.

Correlates of PLMs variability over multiple nights and impact upon RLS diagnosis.

Trotti LM, Bliwise DL, Greer SA, Sigurdsson AP, Gudmundsdóttir GB, Wessel T, Organisak LM, Sigthorsson T, Kristjansson K, Sigmundsson T, Rye DB.

Sleep Med. 2009 Jun;10(6):668-71. doi: 10.1016/j.sleep.2008.06.009. Epub 2008 Nov 20.

PMID:
19022704
48.

An update on the pathophysiology and genetics of restless legs syndrome.

Trotti LM, Bhadriraju S, Rye DB.

Curr Neurol Neurosci Rep. 2008 Jul;8(4):281-7. Review.

PMID:
18590611
49.

Insomnia on dialysis nights: the beneficial effects of cool dialysate.

Parker KP, Bailey JL, Rye DB, Bliwise DL, Van Someren EJ.

J Nephrol. 2008 Mar-Apr;21 Suppl 13:S71-7.

PMID:
18446736

Supplemental Content

Support Center